Creo Medical Group PLC (AIM:CREO)

London flag London · Delayed Price · Currency is GBP · Price in GBX
12.00
-0.13 (-1.03%)
Apr 28, 2026, 2:48 PM GMT
23.08%
Market Cap 48.80M
Revenue (ttm) 4.60M
Net Income (ttm) 500.00K
Shares Out 402.47M
EPS (ttm) -0.00
PE Ratio 54.99
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 270,633
Average Volume 824,751
Open 12.10
Previous Close 12.13
Day's Range 11.75 - 12.50
52-Week Range 9.50 - 18.50
Beta 0.77
RSI 46.87
Earnings Date May 13, 2026

About Creo Medical Group

Creo Medical Group PLC, through its subsidiaries, engages in the research, development, manufacture, and sale of medical devices and instruments for clinics and hospitals in the United Kingdom. It develps CROMA, an energy platform that combines bipolar radiofrequency for precise localized cutting and microwave energy for controlled coagulation, to provide physicians with controllable devices delivered through an endoscope. The company also offers Speedboat Inject, an energy multimodal instrument for endoscopy; MicroBlate Fine, a microwave needl... [Read more]

Industry Medical Devices
Sector Healthcare
Founded 2003
Employees 129
Stock Exchange London Stock Exchange AIM
Ticker Symbol CREO
Full Company Profile

Financial Performance

In 2024, Creo Medical Group's revenue was 4.00 million, a change of 0.00% compared to the previous year's 4.00 million. Losses were -28.70 million, 32.3% more than in 2023.

Financial Statements

News

There is no news available yet.